Sandwich, United Kingdom

Timothy Michael Lukas

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Kent, GB (2004)
  • Sandwich, GB (2019 - 2020)

Company Filing History:


Years Active: 2004-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Timothy Michael Lukas

Introduction

Timothy Michael Lukas is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for intravenous administration. With a total of 4 patents to his name, Lukas continues to push the boundaries of medical innovation.

Latest Patents

Lukas's latest patents focus on formulations of a PI3K/mTOR-inhibitor for intravenous administration. The first patent describes a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. This formulation is particularly suitable for intravenous or parenteral administration to a patient. The second patent also relates to a similar formulation, emphasizing its suitability for intravenous use.

Career Highlights

Timothy Michael Lukas has established a successful career at Pfizer Corporation, where he has been instrumental in advancing pharmaceutical formulations. His work has contributed to the development of innovative treatments that enhance patient care and outcomes.

Collaborations

Lukas has collaborated with notable colleagues, including Stephen Richard Wicks and Kevin Richard Back. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Timothy Michael Lukas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…